カテゴリ： GlobalData, アメリカ, 企業調査

Becton Dickinson and Co (BDX)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Becton Dickinson and Co (BDX) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011716
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月13日
◆ページ数：197
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infectionsand cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company sells its products in the Americas, Europe, the Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.

Becton Dickinson and Co (BDX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 7
List of Figures 9
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2011 to YTD 2017 10
Becton Dickinson and Co, Medical Equipment Deals By Type, 2011 to YTD 2017 11
Becton Dickinson and Co, Medical Equipment, Deals By Region, 2011 to YTD 2017 12
Becton Dickinson and Co, Medical Equipment, Deals By Market, 2011 to YTD 2017 13
Becton Dickinson and Co, Medical Equipment, Deals Summary, 2011 to YTD 2017 15
Becton Dickinson and Co, Medical Equipment, Deal Details 21
Asset Purchase 21
Becton, Dickinson Rumored to Sell Respiratory Devices Business 21
Venture Financing 22
Medaware Raises USD8 Million in Series A Financing 22
GenCell Biosystems Raises US$3.5 Million In Seed Financing Round 23
Sirigen Secures US$3 Million In Venture Financing 24
Private Equity 25
UK Medical’s Managment Acquires Company from Becton Dickinson 25
CareFusion Reportedly Elicits Acquisition Interest From Private Equity Firms 26
Partnerships 27
Roche Enters into Licensing Agreement with Becton Dickinson 27
Vancive Medical Enters Into Licensing Agreement With CareFusion For Antimicrobial Dressing 28
Asuragen Enters Into Licensing Agreement With Becton, Dickinson 29
SDIX Enters Into Licensing Agreement With BD Diagnostic 30
Acacia Research Enters Into Licensing Agreement With Becton, Dickinson And Argon Medical 31
Becton, Dickinson Enters Into Licensing Agreement With Advanced Analytical Technologies For Micro PRO Microbial Detection System 32
UCL Business Enters Into Licensing Agreement With Becton, Dickinson 33
Noble Enters into Agreement with Becton Dickinson 34
Becton Dickinson and UniteOR Enter into Agreement 35
Becton, Dickinson Enters into Research Agreement with Juvenile Diabetes Research Foundation 36
Becton, Dickinson Forms Joint Venture with Apax Partners 37
Becton Dickinson and Singapore Immunology Network Enter into Research Agreement 38
Becton, Dickinson Enters into Distribution Agreement with Check-Points 39
Becton, Dickinson Enters into Co-Marketing Agreement with Sight Diagnostics 40
CareFusion Enters into Distribution Agreement with ResMed 41
CareFusion Enters into Distribution Agreement with AAM Healthcare 42
Edwards Lifesciences Enters into Agreement with CareFusion 43
Seegene Enters into Co-Development Agreement with BD Life Sciences 44
Becton, Dickinson Enters into Agreement with FlowJo 45
BD Life Sciences Enters into Co-Marketing with Cellular Research 46
Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 47
CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 48
Becton, Dickinson Enters into Agreement with Aethon to Develop Integrated Medication Management Solution 49
GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 50
Terumo Enters Into Distribution Agreement With CareFusion For SurFlash Catheters In US 51
Becton, Dickinson Enters Into Collaboration Agreement With CME Medical For Saf-T-Intima Safety Integrated IV Catheter System 52
Juvenile Diabetes Research Extends Co-Development Agreement With Becton, Dickinson For Infusion And Glucose Monitoring Device 53
BD Diagnostics Amends Agreement With Bruker For BD Bruker Maldi Biotyper System 54
CytoVas And BD Biosciences Enter Into Co-Development Agreement For Vascular Health Diagnostics 55
Intelligent Hospital Systems Enters Into Technology Integration Agreement With Cato Software Solutions 56
BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays 57
University of Limerick Enters Into Co-Development Agreement With GenCell 58
Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test 59
Juvenile Diabetes Research Foundation Extends Co-Development Agreement With Becton, Dickinson 60
CareFusion Extends Distribution Agreement With Fisher & Paykel Healthcare 61
BD Diagnostics Enters Into Co-Development Agreement With Biodiversity 62
BD Diagnostics Enters Into Co-Development Agreement With Lab21 63
CareFusion Enters Into Distribution Agreement With ResMed 64
B. Braun Medical Enters Into Distribution Agreement With CME America 65
BD Diagnostic Enters Into Co-Development Agreement With Diagenode 66
West Pharma Enters Into Agreement With CareFusion 67
Becton, Dickinson Enters into Licensing Agreement with DiabetOmics 68
Equity Offering 69
Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares 69
Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares 71
Becton, Dickinson Files Registration Statement For Public Offering Of Securities 73
Debt Offering 74
Becton, Dickinson Raises USD 826.05 Million in Public Offering of 0.368% Notes Due 2019 74
Becton, Dickinson Raises USD2.4 Billion in Public Offering of 3.7% Notes Due 2027 75
Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020 76
Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024 77
Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019 78
Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022 79
Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047 80
Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022 81
Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 82
Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 84
Becton, Dickinson Raises USD1.25 Billion in Public Offering of 1.8% Notes Due 2017 86
Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due 2019 88
Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due 2024 90
Becton, Dickinson Raises USD1.2 Billion in Public Offering of 4.685% Notes Due 2044 92
Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due 2016 94
CareFusion Raises USD300 Million in Private Placement of Notes Due 2017 96
CareFusion Raises USD400 Million in Public Offering of Notes Due 2024 98
CareFusion Raises USD300 Million in Public Offering of Notes Due 2044 99
CareFusion Completes Private Placement Of Notes Due 2023 For US$300 Million 100
Becton, Dickinson Completes Public Offering Of Notes Due 2016 For US$500 Million 101
Becton, Dickinson Completes Public Offering Of Notes Due 2021 For US$1 Billion 102
Asset Transactions 103
Merit Medical to Acquire Product Line from Becton, Dickinson for USD100 Million 103
Stryker Acquires Vertebral Augmentation Solutions Business from Becton, Dickinson 105
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 106
Becton, Dickinson May Divest Surgical Instruments Unit 107
Corning Completes Acquisition of Majority Stake In Discovery Labware Unit Of Becton, Dickinson For US$730 Million 108
Natus Medical Completes Acquisition Of Nicolet Business From CareFusion For US$58 Million 110
Medline Completes Acquisition Of International Surgical Products Distribution Business From CareFusion 112
CareFusion Sells OnSite Services Instrument Management and Repair Business To Frazier Healthcare 113
Acquisition 114
Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 114
Becton, Dickinson Acquires Remaining 60% Stake in Caesarea Medical Electronics 116
Becton, Dickinson Acquires Cellular Research 117
Becton, Dickinson Acquires CareFusion for USD12.2 Billion 118
BD Acquires CRISI Medical Systems 120
Becton, Dickinson Acquires GenCell Biosystems 121
Becton, Dickinson Acquires Alverix From Safeguard Scientifics And New Venture Partners For US$40 Million 122
CareFusion Completes Partial Acquisition Of Vital Signs From GE Healthcare For US$470 Million 124
CareFusion Acquires Stake In Sendal From GED Capital 125
Becton, Dickinson Acquires Cato Software Solutions, Maker Of Medical Software Solutions 126
Becton, Dickinson Completes Acquisition Of Safety Syringes, Developer Of Anti-Needlestick Devices 127
Carefusion Completes Acquisition Of Intermed Equipamento Medico Hospitalar, Respiratory Device Company 128
Becton, Dickinson Acquires Sirigen, Developer Of Polymer Dyes 129
CareFusion Acquires UK Medical, Distributor Of Medical Products 131
Becton, Dickinson Acquires KIESTRA, Provider Of Lab Automation Solutions 132
Becton, Dickinson Completes Acquisition Of Carmel Pharma 133
CareFusion Completes Acquisition Of Rowa For US$150 Million 135
Becton, Dickinson Completes Acquisition Of Accuri Cytometers 136
Becton Dickinson and Co – Key Competitors 138
Becton Dickinson and Co – Key Employees 139
Becton Dickinson and Co – Locations And Subsidiaries 141
Head Office 141
Other Locations & Subsidiaries 141
Recent Developments 148
Strategy And Business Planning 148
Oct 25, 2017: BD Breaks Ground on $60 Million Expansion of Nebraska Manufacturing Facility 148
Jun 13, 2017: FlowJo and BD to Provide Cloud Platform for Real-Time Single-Cell Marketing Collaboration 149
May 09, 2017: BD and UniteOR to develop new surgical tray management solution 150
Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges 151
Financial Announcements 152
Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 152
May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 154
Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter 156
Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 158
Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 160
May 05, 2016: BD Announces Results For 2016 Second Fiscal Quarter 162
Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter 164
Corporate Communications 166
Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 166
Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 167
Legal and Regulatory 168
Oct 31, 2017: Eastern District Court Denies Motion to Reconsider Becton, Dickinson and Co. Judgment 168
Sep 15, 2017: Retractable Technologies Files Motions in Connection with Becton, Dickinson Judgment 169
Aug 18, 2017: District Court Issues Final Judgment – Retractable Technologies v. Becton, Dickinson 170
Mar 21, 2017: Retractable Technologies Announces Litigation Updates 171
Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit’s Opinion 172
Jun 06, 2016: B. Braun Medical and Affiliates Sue Becton, Dickinson for IV Catheter Safety Mechanism Patent Infringements 173
Government and Public Interest 174
Jun 06, 2017: BD Releases 2016 Sustainability Report 174
Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 175
Product News 176
Dec 04, 2017: BD Announces New Offerings to Help Customers Deliver Safer, Simpler and Smarter Medication Management 176
Nov 16, 2017: BD to Introduce Integrated Medication Management Platform Designed to Address Hospitals’ Greatest Challenges at ASHP17 178
Apr 27, 2017: BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering 179
Feb 20, 2017: BD Demonstrates Synchronized Technology Platform at HIMSS17 180
Dec 05, 2016: BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management 181
Sep 12, 2016: BD Announces New Software Release for Pyxis Enterprise Solution 182
May 26, 2016: BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody System 183
03/01/2016: BD Receives CE Mark for Next Generation Blood Separation Technology 184
03/01/2016: BD Utilizes AT&T Connectivity to Offer Connected Wireless Health Devices 185
Feb 12, 2016: BD Unveils New Next Generation Sequencing Library Prep System at the 2016 Advances in Genome Biology and Technology Meeting 186
02/10/2016: BD Receives FDA 510(k) Clearance for Diagnostic Device for HIV/AIDS 187
Feb 08, 2016: BD Launches BD FACSymphony High-Speed Cell Analyzer to Enable Identification and Analysis of Rare Cell Types 188
Product Approvals 189
Mar 01, 2016: BD Receives CE Mark for Next Generation Blood Separation Technology 189
Feb 10, 2016: BD Receives FDA 510(k) Clearance for Diagnostic Device for HIV/AIDS 190
Other Significant Developments 191
Aug 24, 2017: BD Helps Thun Hospital Advance Medication Management Into the Future 191
Jul 18, 2017: BD Transforms Microbiology Urine Testing 193
May 09, 2017: BD and UniteOR to develop new surgical tray management solution 194
Feb 13, 2017: BD Announces Early Access Program for BD Resolve Single-Cell Analysis Platform 195
Sep 22, 2016: BD Invests $100 Million In Nebraska Plant To Expand Insulin Syringe Manufacturing 196
Appendix 197
Methodology 197
About GlobalData 197
Contact Us 197
Disclaimer 197

List of Tables
Becton Dickinson and Co, Medical Equipment, Key Facts, 2016 2
Becton Dickinson and Co, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2011 to YTD 2017 10
Becton Dickinson and Co, Medical Equipment Deals By Type, 2011 to YTD 2017 11
Becton Dickinson and Co, Medical Equipment, Deals By Region, 2011 to YTD 2017 12
Becton Dickinson and Co, Deals By Market, 2011 to YTD 2017 13
Becton Dickinson and Co, Medical Equipment, Deals Summary, 2011 to YTD 2017 15
Becton, Dickinson Rumored to Sell Respiratory Devices Business 21
Medaware Raises USD8 Million in Series A Financing 22
GenCell Biosystems Raises US$3.5 Million In Seed Financing Round 23
Sirigen Secures US$3 Million In Venture Financing 24
UK Medical’s Managment Acquires Company from Becton Dickinson 25
CareFusion Reportedly Elicits Acquisition Interest From Private Equity Firms 26
Roche Enters into Licensing Agreement with Becton Dickinson 27
Vancive Medical Enters Into Licensing Agreement With CareFusion For Antimicrobial Dressing 28
Asuragen Enters Into Licensing Agreement With Becton, Dickinson 29
SDIX Enters Into Licensing Agreement With BD Diagnostic 30
Acacia Research Enters Into Licensing Agreement With Becton, Dickinson And Argon Medical 31
Becton, Dickinson Enters Into Licensing Agreement With Advanced Analytical Technologies For Micro PRO Microbial Detection System 32
UCL Business Enters Into Licensing Agreement With Becton, Dickinson 33
Noble Enters into Agreement with Becton Dickinson 34
Becton Dickinson and UniteOR Enter into Agreement 35
Becton, Dickinson Enters into Research Agreement with Juvenile Diabetes Research Foundation 36
Becton, Dickinson Forms Joint Venture with Apax Partners 37
Becton Dickinson and Singapore Immunology Network Enter into Research Agreement 38
Becton, Dickinson Enters into Distribution Agreement with Check-Points 39
Becton, Dickinson Enters into Co-Marketing Agreement with Sight Diagnostics 40
CareFusion Enters into Distribution Agreement with ResMed 41
CareFusion Enters into Distribution Agreement with AAM Healthcare 42
Edwards Lifesciences Enters into Agreement with CareFusion 43
Seegene Enters into Co-Development Agreement with BD Life Sciences 44
Becton, Dickinson Enters into Agreement with FlowJo 45
BD Life Sciences Enters into Co-Marketing with Cellular Research 46
Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 47
CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 48
Becton, Dickinson Enters into Agreement with Aethon to Develop Integrated Medication Management Solution 49
GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 50
Terumo Enters Into Distribution Agreement With CareFusion For SurFlash Catheters In US 51
Becton, Dickinson Enters Into Collaboration Agreement With CME Medical For Saf-T-Intima Safety Integrated IV Catheter System 52
Juvenile Diabetes Research Extends Co-Development Agreement With Becton, Dickinson For Infusion And Glucose Monitoring Device 53
BD Diagnostics Amends Agreement With Bruker For BD Bruker Maldi Biotyper System 54
CytoVas And BD Biosciences Enter Into Co-Development Agreement For Vascular Health Diagnostics 55
Intelligent Hospital Systems Enters Into Technology Integration Agreement With Cato Software Solutions 56
BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays 57
University of Limerick Enters Into Co-Development Agreement With GenCell 58
Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test 59
Juvenile Diabetes Research Foundation Extends Co-Development Agreement With Becton, Dickinson 60
CareFusion Extends Distribution Agreement With Fisher & Paykel Healthcare 61
BD Diagnostics Enters Into Co-Development Agreement With Biodiversity 62
BD Diagnostics Enters Into Co-Development Agreement With Lab21 63
CareFusion Enters Into Distribution Agreement With ResMed 64
B. Braun Medical Enters Into Distribution Agreement With CME America 65
BD Diagnostic Enters Into Co-Development Agreement With Diagenode 66
West Pharma Enters Into Agreement With CareFusion 67
Becton, Dickinson Enters into Licensing Agreement with DiabetOmics 68
Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares 69
Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares 71
Becton, Dickinson Files Registration Statement For Public Offering Of Securities 73
Becton, Dickinson Raises USD 826.05 Million in Public Offering of 0.368% Notes Due 2019 74
Becton, Dickinson Raises USD2.4 Billion in Public Offering of 3.7% Notes Due 2027 75
Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020 76
Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024 77
Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019 78
Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022 79
Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047 80
Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022 81
Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 82
Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 84
Becton, Dickinson Raises USD1.25 Billion in Public Offering of 1.8% Notes Due 2017 86
Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due 2019 88
Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due 2024 90
Becton, Dickinson Raises USD1.2 Billion in Public Offering of 4.685% Notes Due 2044 92
Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due 2016 94
CareFusion Raises USD300 Million in Private Placement of Notes Due 2017 96
CareFusion Raises USD400 Million in Public Offering of Notes Due 2024 98
CareFusion Raises USD300 Million in Public Offering of Notes Due 2044 99
CareFusion Completes Private Placement Of Notes Due 2023 For US$300 Million 100
Becton, Dickinson Completes Public Offering Of Notes Due 2016 For US$500 Million 101
Becton, Dickinson Completes Public Offering Of Notes Due 2021 For US$1 Billion 102
Merit Medical to Acquire Product Line from Becton, Dickinson for USD100 Million 103
Stryker Acquires Vertebral Augmentation Solutions Business from Becton, Dickinson 105
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 106
Becton, Dickinson May Divest Surgical Instruments Unit 107
Corning Completes Acquisition of Majority Stake In Discovery Labware Unit Of Becton, Dickinson For US$730 Million 108
Natus Medical Completes Acquisition Of Nicolet Business From CareFusion For US$58 Million 110
Medline Completes Acquisition Of International Surgical Products Distribution Business From CareFusion 112
CareFusion Sells OnSite Services Instrument Management and Repair Business To Frazier Healthcare 113
Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 114
Becton, Dickinson Acquires Remaining 60% Stake in Caesarea Medical Electronics 116
Becton, Dickinson Acquires Cellular Research 117
Becton, Dickinson Acquires CareFusion for USD12.2 Billion 118
BD Acquires CRISI Medical Systems 120
Becton, Dickinson Acquires GenCell Biosystems 121
Becton, Dickinson Acquires Alverix From Safeguard Scientifics And New Venture Partners For US$40 Million 122
CareFusion Completes Partial Acquisition Of Vital Signs From GE Healthcare For US$470 Million 124
CareFusion Acquires Stake In Sendal From GED Capital 125
Becton, Dickinson Acquires Cato Software Solutions, Maker Of Medical Software Solutions 126
Becton, Dickinson Completes Acquisition Of Safety Syringes, Developer Of Anti-Needlestick Devices 127
Carefusion Completes Acquisition Of Intermed Equipamento Medico Hospitalar, Respiratory Device Company 128
Becton, Dickinson Acquires Sirigen, Developer Of Polymer Dyes 129
CareFusion Acquires UK Medical, Distributor Of Medical Products 131
Becton, Dickinson Acquires KIESTRA, Provider Of Lab Automation Solutions 132
Becton, Dickinson Completes Acquisition Of Carmel Pharma 133
CareFusion Completes Acquisition Of Rowa For US$150 Million 135
Becton, Dickinson Completes Acquisition Of Accuri Cytometers 136
Becton Dickinson and Co, Key Competitors 138
Becton Dickinson and Co, Key Employees 139
Becton Dickinson and Co, Other Locations 141
Becton Dickinson and Co, Subsidiaries 142

★海外企業調査レポート[Becton Dickinson and Co (BDX)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Bloomin’ Brands Inc：企業の戦略・SWOT・財務分析
    Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report Summary Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Jaiprakash Associates Ltd (JPASSOCIAT)：企業の財務・戦略的SWOT分析
    Jaiprakash Associates Ltd (JPASSOCIAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Epinex Diagnostics Inc：医療機器：M&Aディール及び事業提携情報
    Summary Epinex Diagnostics Inc (Epinex Diagnostics) is a medical device company that develops rapid diagnostic tests. The company’s products include over-the-counter test device, Epinex G1A Test system, Epinex ACR Test system, Epinex SimplySure PT-INR Test system and point-of-care test device, among …
  • Beaver Aerospace & Defense, Inc.：企業の戦略・SWOT・財務分析
    Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Five Prime Therapeutics Inc (FPRX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Five Prime Therapeutics Inc (Five Prime) is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic protei …
  • Gujarat State Electricity Corp Ltd：企業の戦略的SWOT分析
    Gujarat State Electricity Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Rentokil Initial plc (RTO)：企業の財務・戦略的SWOT分析
    Rentokil Initial plc (RTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ok Tedi Mining Ltd：企業の戦略・SWOT・財務情報
    Ok Tedi Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Ok Tedi Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ingles Markets Inc：企業の戦略・SWOT・財務情報
    Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report Summary Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bangladesh Power Development Board-エネルギー分野：企業M&A・提携分析
    Summary Bangladesh Power Development Board (BPDB) is an integrated energy statutory board. It generates electricity through owned power plants and procures electricity from public and private generation companies. The board utilizes gas, coal, hydro, furnace oil, and diesel as fuel source for electr …
  • Apricus Biosciences Inc (APRI)：製薬・医療：M&Aディール及び事業提携情報
    Summary Apricus Biosciences Inc (Apricus) develops and commercializes pharmaceutical products indicated for the treatment of various therapeutic classes including urology and rheumatology. Its product pipeline includes, Vitaros (alprostadil), a topical vasodilator cream in-licensed from Warner Chilc …
  • Progenity Inc：医療機器：M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …
  • Solco Biomedical Co Ltd (043100)-医療機器分野：企業M&A・提携分析
    Summary Solco Biomedical Co Ltd (Solco) is a medical device company that manufactures surgical instruments. The company develops and produces implants for orthopedics, neurosurgery, surgical instruments and home functional health products. It offers implants, instruments and health care products. So …
  • Quest PharmaTech Inc (QPT)：製薬・医療：M&Aディール及び事業提携情報
    Summary Quest PharmaTech Inc (Quest), formerly Altachem Pharma Ltd is a pharmaceutical company that develops antibody based immunotherapeutic products for the treatment of cancer. The company develops products for treatment of cancer by combining immunotherapeutic antibodies with immunoglobulin G or …
  • Novartis AG (NOVN)：企業の財務・戦略的SWOT分析
    Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • UIL Energy Ltd (UIL)：石油・ガス：M&Aディール及び事業提携情報
    Summary UIL Energy Ltd (UIL Energy) is an oil and gas company. The company provides business activities such as exploration for reserves of both conventional and unconventional oil and natural gas plays in proven hydrocarbon basins in Western Australia. It offers portfolio such as gas and liquids th …
  • Malayan Banking Berhad：企業のM&A・事業提携・投資動向
    Malayan Banking Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Malayan Banking Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Takeda Pharmaceuticals USA Inc-製薬・医療分野：企業M&A・提携分析
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • Kaken Pharmaceutical Co Ltd (4521)：企業の財務・戦略的SWOT分析
    Kaken Pharmaceutical Co Ltd (4521) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • KPC Pharmaceuticals Inc (600422)-製薬・医療分野：企業M&A・提携分析
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xue …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆